TIGIT and head and neck squamous cell carcinoma: Moreover, frequencies of circulating CD4 and CD8 T cells expressing the immunostimulatory checkpoint GITR (Figures 7A, B, E) or the inhibitory receptor TIGIT (Figures 7C, D, F) were significantly increased in HNSCC patients compared with controls.